ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1331

Change in MRI in Patients with Spondyloarthritis Treated with Anti-TNF Agents : Systematic Review of the Literature

Gisèle KHOURY1, BG Combe2 and Cédric Lukas3, 1Rheumatology, Hopital Lapeyronie, Montpellier, France, 2Lapeyronie, Montpellier, France, 3Hopital Lapeyronie, Montpellier, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: anti-TNF therapy, meta-analysis and spondylarthritis, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The follow-up of axial spondyloarthritis (SpA) remains difficult in clinical practice, mainly based on patient-reported outcomes, whereas objective parameters in disease monitoring are often lacking, especially in axial manifestations. MRI of the spine and sacroiliac joints (SIJ) might be relevant for difficult cases, provided that its validity and correlation with clinical, biological parameters, functional and activity scores is ascertained.

The aim of this study was to assess the effect of TNF alpha inhibitors (TNF-) on MRI scoring of inflammation on spine and SIJ and to evaluate their correlation with the clinical and biological parameters used in daily practice.

Methods: A systematic review of the literature using PUBMED and the Cochrane library as well as proceedings from recent major relevant congresses was performed until January 2015. All randomized controlled trials and controlled cohorts reporting the effect of TNF- on spine and SIJ MRI scores (ASspiMRI, SPARCC, Berlin) were selected. Data were collected using a predetermined form. The outcomes were: the change in scores between baseline and follow up in TNF- and control groups, the correlation of theses changes with CRP, ESR, BASDAI, BASFI, ASDAS, pain and morning stiffness. When appropriate, statistical analysis determined the pooled therapeutic effect of TNF- on MRI scores computed by meta-analysis.

Results: Out of 365 screened references, 58 studies were included : 14 using ASspiMRI score, 8 using spine SPARCC score, 8 using SPARCC SIJ score, 7 using BERLIN spine score, 7 using BERLIN SIJ score and 14 using other scores. In ASspiMRi at 12 weeks and 2years follow up, and in SPARCC spine score at 12 weeks follow up a non significant difference in MRI score decrease between the TNF alpha inhibitor group and control group was reported. A significant decrease in the SPARCC SIJ score at 12 weeks in TNF alpha inhibitor group was reported. The correlation between MRI spine and SIJ scores on one side, and the clinical and biological data on the other side was very heterogeneous across the different reports. However, an association was usually reported between the MRI scores and CRP, ESR and ASDAS.

Conclusion: Considering our findings, MRI (especially MRI of the spine) seems to insufficiently reflect the axial activity of SpA patients to recommend its use in individual follow-up or assessment of patients. Regarding its diagnostic value or relevance in the apprehension of the pathophysiology of the disease however, it remains currently the most accurate tool.


Disclosure: G. KHOURY, None; B. Combe, Pfizer, Roche-Chugai, 2,BMS, Merck, Pfizer, Roche-Chugai, UCB, 8; C. Lukas, None.

To cite this abstract in AMA style:

KHOURY G, Combe B, Lukas C. Change in MRI in Patients with Spondyloarthritis Treated with Anti-TNF Agents : Systematic Review of the Literature [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/change-in-mri-in-patients-with-spondyloarthritis-treated-with-anti-tnf-agents-systematic-review-of-the-literature/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/change-in-mri-in-patients-with-spondyloarthritis-treated-with-anti-tnf-agents-systematic-review-of-the-literature/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology